BBLG Q4 2020 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$206,432

Net Income

-$453,711

EPS (Diluted)

$-88.06

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$125,693

Free Cash Flow

-$125,690

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$0

Total Liabilities

$14M

Stockholders' Equity

-$14M

Cash & Equivalents

$0

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$206,432	-$277,629	+25.6%
Net Income	-$453,711	-$531,147	+14.6%